Hi, mooers!
$Taiwan Semiconductor (TSM.US)$ is releasing its Q3 2024 earnings on October 17 before the bell. Unlock insights with TSM Earnings Hub>>
For the details of indicator sentiment, please tap the link and check.
Since its Q2 2024 earnings release, shares of $Taiwan Semiconductor (TSM.US)$ have seen an increase of 11.42%.How will the market react to the upcoming results? Make your guess now!
Rewards
● An equal share of 5,000 ...

$Fullerton SGD Cash Fund (SG9999005961.MF)$ haven’t received my 5.8% return, countdown reached 0 days on 22 jan. @Moomoo Buddy please help!

$Apple (AAPL.US)$ is releasing its Q4 FY2023 earnings on November 2 after the bell. How will the market react to the company's quarterly results? Vote your answer to participate!
Rewards
● An equal share of 1,000 points: For mooers who correctly guess the price range of $Apple (AAPL.US)$'s opening price at 9:30 AM ET November 3 (e.g., If 50 mooers make a correct guess, each of them will get 20 points.)
 (Vote will...

"WoodSis" launched the ninth ETF last night,
It is understood that $ARK TRANSPARENCY ETF (CTRU.US)$ is the ninth ETF and the third index fund.
ARK believes that the company's transparency can give investors confidence and provide the potential for long-term growth in stock prices. Therefore,
The original intention of ARK Transparency ETF is to track the Transparency Index.
Comparison of the cumulative returns of the S&P 500 Index and the Transparency Index (blue represents the Transparency Index, yellow represents the S&P 500).
It is understood that the new fund has a fee rate of 0.55%. In addition, the ETF will hold 100 stocks, with the highest holdings being Cloudflare (NETUS), Bloom Energy (BE.US), and Enphase Energy (ENPH.US).
Wood's actively managed ETF has been criticized since the beginning of the year. At the launch of the new ETF, Wood and her flagship fund $ARK Innovation ETF (ARKK.US)$ Just recorded the worst one-week performance since February, dropping 12.7% to the lowest level in over a year. 6 out of the company's 8 ETFs recorded declines in 2021, with the worst performance coming from $ARK Genomic Revolution ETF (ARKG.US)$ , dropping by 37%.

As year 2021 draws to a close, it is time to reflect and count our blessings. 2021 is probably one of my most difficult years to date. It is a year I am not likely to forget as we had a health scare in the family which added to the stress of coping with the pandemic.
For almost two years, I have had to forgo or keep to a minimum things I had previously taken for granted — shaking hands, visiting family and friends, dining out, taking off overseas, visiting malls, going to the cinema, visiting the dentist, having a haircut, etc.
Reading the accounts of people who recovered from COVID-19 brought home to me the preciousness of simple pleasures like having our loved ones close to us, going outdoors and being able to taste and smell.
I’m immensely grateful for:
1. The people who love and care for me.
2. The roof over our heads and the food on our table.
3. The first class healthcare system in my country.
4. The selfless and dedicated folks working at the frontline. In particular, I want to thank the healthcare workers who have worked so hard for so long.
5. Having internet access which keeps me connected with people whom I cannot meet face to face and up to date with my investments. The ones that did well were $NetLink NBN Tr (CJLU.SG)$  $DBS Group Holdings (D05.SG)$  $CapitaLandInvest (9CI.SG)$ and  $CapLand IntCom T (C38U.SG)$ .
6. Last but not least, the discovery of moomoo and its powerful app so I can access quality charts, news and market data quickly. Moomoo gave me my first $Apple (AAPL.US)$ share and helped to broaden my knowledge about trading in the US market. It will always have a special place in my heart because of this. I’m also thankful for the friends I’ve made through Moomoo.
Even in the darkest cloud, there is always a silver lining.
Happy Thanksgiving and all the best in your investment!

$Pfizer (PFE.US)$ $Moderna (MRNA.US)$ a possible 10% raise when pfizer shares if they have the similar capabilities with Moderna?